1-4 of 4
Koichi Watamoto, MD
Close
Sort by
Journal Articles

Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia

Jeong Hui Kim, Yasuhiko Harada, MD PhD, Yuichi Ishikawa, MD PhD, Naomi Kawashima, MD PhD, Marie Nakashima, MD, Yoko Ushijima, MD PhD, Takahiro Nishiyama, MD PhD, Tatsunori Goto, MD PhD, Nobuaki Fukushima, MD PhD, Rika Kihara, MD PhD, Tomohiro Kajiguchi, MD PhD, Koichi Watamoto, MD PhD, Akio Kohno, MD PhD, Kunio Kitamura, MD PhD, Yukiyasu Ozawa, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1418.
https://doi.org/10.1182/blood-2019-127610
Published: 2019
Journal Articles

Effect of Speciallist Palliative Care Service on End-of Life Care in Patients with Hematologic Malignancies

Rika Kihara, MD PhD, Yumi Ishiguri, MD, Norihiro Ueda, MD, Yasuyuki Asai, MD, Takuya Odagiri, MD, Koichi Watamoto, MD PhD, Hiroaki Watanabe, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2242.
https://doi.org/10.1182/blood-2018-99-110127
Published: 2018
Journal Articles

A Plasma Marker Panel Diagnostic for Dismal Transplant-Related Complications

Kazutaka Ozeki, MD PhD, Akio Kohno, MD PhD, Yohei Yamaguchi, MD, Koji Umemura, MD, Yoshitaka Adachi, MD, Koichi Watamoto, MD PhD, Yoshihisa Morishita, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1159.
https://doi.org/10.1182/blood.V124.21.1159.1159
Published: 2014
Journal Articles

Predictive and Diagnostic Value Of Circulating Angiopoietin-2 For Transplant-Related Complications

Yoshihisa Morishita, MD, PhD, Norihiro Ueda, MD, Dai Chihara, MD, PhD, Shotaro Tatekawa, MD, Kazutaka Ozeki, MD, PhD, Koichi Watamoto, MD, Akio Kohno, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3279.
https://doi.org/10.1182/blood.V122.21.3279.3279
Published: 2013